Evidence map›Paper›PMID 36734974›Full record

ArticleeLife2023

The termination of UHRF1-dependent PAF15 ubiquitin signaling is regulated by USP7 and ATAD5.

Ryota Miyashita, Atsuya Nishiyama, Weihua Qin, Yoshie Chiba, Satomi Kori, Norie Kato, Chieko Konishi, Soichiro Kumamoto, Hiroko Kozuka-Hata, Masaaki Oyama and 6 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Ryota MiyashitaDivision of Cancer Cell Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0003-1452-8829
Atsuya NishiyamaDivision of Cancer Cell Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-8416-3776
Weihua QinFaculty of Biology, Ludwig-Maximilians-Universität München, Munich, Germany.
Yoshie ChibaDivision of Cancer Cell Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Satomi KoriStructural Biology Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.
Norie KatoStructural Biology Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.
Chieko KonishiDivision of Cancer Cell Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Soichiro KumamotoDivision of Cancer Cell Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Hiroko Kozuka-HataMedical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Masaaki OyamaMedical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Yoshitaka KawasoeLaboratory of Chromosome Biology, Department of Biology, Faculty of Science, Kyushu University, Fukuoka, Japan.
Toshiki TsurimotoLaboratory of Chromosome Biology, Department of Biology, Faculty of Science, Kyushu University, Fukuoka, Japan.
Tatsuro S TakahashiLaboratory of Chromosome Biology, Department of Biology, Faculty of Science, Kyushu University, Fukuoka, Japan.ORCID 0000-0002-1947-7680
Heinrich LeonhardtFaculty of Biology, Ludwig-Maximilians-Universität München, Munich, Germany.
Kyohei AritaStructural Biology Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.ORCID 0000-0002-9762-8405
Makoto NakanishiDivision of Cancer Cell Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-6707-3584
The University of Tokyo · JPKyushu University · JPYokohama City University · JPLudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

UHRF1-dependent ubiquitin signaling plays an integral role in the regulation of maintenance DNA methylation. UHRF1 catalyzes transient dual mono-ubiquitylation of PAF15 (PAF15Ub2), which regulates the localization and activation of DNMT1 at DNA methylation sites during DNA replication. Although the initiation of UHRF1-mediated PAF15 ubiquitin signaling has been relatively well characterized, the mechanisms underlying its termination and how they are coordinated with the completion of maintenance DNA methylation have not yet been clarified. This study shows that deubiquitylation by USP7 and unloading by ATAD5 (ELG1 in yeast) are pivotal processes for the removal of PAF15 from chromatin. On replicating chromatin, USP7 specifically interacts with PAF15Ub2 in a complex with DNMT1. USP7 depletion or inhibition of the interaction between USP7 and PAF15 results in abnormal accumulation of PAF15Ub2 on chromatin. Furthermore, we also find that the non-ubiquitylated form of PAF15 (PAF15Ub0) is removed from chromatin in an ATAD5-dependent manner. PAF15Ub2 was retained at high levels on chromatin when the catalytic activity of DNMT1 was inhibited, suggesting that the completion of maintenance DNA methylation is essential for the termination of UHRF1-mediated ubiquitin signaling. This finding provides a molecular understanding of how the maintenance DNA methylation machinery is disassembled at the end of the S phase.

Indexed as

UbiquitinUbiquitin-Protein LigasesCCAAT-Enhancer-Binding ProteinsChromatinDNA (Cytosine-5-)-Methyltransferase 1DNA MethylationProtein BindingUbiquitin-Specific Peptidase 7CCAAT-Enhancer-Binding ProteinsChromatinDNA (Cytosine-5-)-Methyltransferase 1UbiquitinUbiquitin-Protein LigasesUbiquitin-Specific Peptidase 7ATAD5cell biologyDNA methylationDNMT1PAF15USP7xenopus

Identifiers

PMID36734974
PMCPMC9943068
OpenAlexW4319058723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.